Advertisement
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 6 to 10

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Doxylamine-pyridoxine may be beneficial for nausea and vomiting symptoms in early pregnancy

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

0
Greater improvement in symptom scores versus placebo, but clinical relevance unclear

CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable Danger

0

Agency notes that counterfeit pills often contain fentanyl and methamphetamine

Nocebo hyperalgesia is stronger when an inert treatment is labeled as being an expensive medication rather than a cheap one

Stronger Nocebo Effect When Inert Rx Labeled As Expensive

0
Neural interactions between cortex, brainstem, and spinal cord mediate this effect
Antiepileptic drug use may increase the risk for pneumonia in patients with Alzheimer disease

AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients

0
Risk for pneumonia highest within first month of antiepileptic drug use but persists through two years
In 2015

Serious Suffering Affects Almost Half of Those Who Die Yearly

0
Vast majority who experience serious health-related suffering have no palliative care, pain relief
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 29 to July 3

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
For women with urinary tract infections

Sulfonamides, Nitrofurantoin Being Given for UTI in Pregnancy

0
Nitrofurantoin, trimethoprim-sulfamethoxazole prescribed first trimester despite ACOG recs

Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema

0

Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis

Engaging in abusive supervisory behavior may be associated with short-term beneficial effects

Short-Lived Benefits for Abusive Supervisory Behavior

0
Positive indirect effect on work engagement via recovery level, which is short-lived